Patents by Inventor Cong-Yi Wang

Cong-Yi Wang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antibodies against SUMO4 polypeptides
    Patent number: 7847069
    Abstract: Antibodies selectively directed against SUM04 polypeptides are provided. The antibodies are useful research tools and further in the diagnosis and treatment of Type 1 diabetes.
    Type: Grant
    Filed: February 5, 2007
    Date of Patent: December 7, 2010
    Assignee: Medical College of Georgia Research Institute
    Inventors: Jin-Xiong She, Cong-Yi Wang
  • Novel Sumo4 Polypeptides and Methods of Use for Type 1 Diabetes
    Publication number: 20070225480
    Abstract: Novel nucleic acids associated with Type 1 diabetes. Also provided are polypeptides encoded by the nucleic acids associated with T1D. The invention also provides methods for facilitating the diagnosis or pre-diagnosis of T1D through the use of such nucleic acids and polypeptides. This invention further provides compositions for the treatment of Type 1 diabetes.
    Type: Application
    Filed: February 5, 2007
    Publication date: September 27, 2007
    Inventors: Jin-Xiong She, Cong-Yi Wang
  • SUMO4 gene and methods of use for type 1 diabetes
    Patent number: 7173119
    Abstract: Novel nucleic acids associated with Type 1 diabetes. Also provided are polypeptides encoded by the nucleic acids associated with T1D. The invention also provides methods for facilitating the diagnosis or pre-diagnosis of T1D through the use of such nucleic acids and polypeptides. This invention further provides compositions for the treatment of Type 1 diabetes.
    Type: Grant
    Filed: March 25, 2005
    Date of Patent: February 6, 2007
    Assignee: Medical College of Georgia Research Institute
    Inventors: Jin-Xiong She, Cong-Yi Wang
  • ACTIVATORS OF CYCLIN-DEPENDENT KINASES
    Publication number: 20060099701
    Abstract: A new gene family involved in cell cycle regulation was discovered. This family has been termed activators of cyclin-dependent kinases (ACDKs). A number of ACDK genes have been cloned and sequenced. Proteins encoded by ACDK genes specifically were shown to interact with CDKs and pRb, and to upregulate the kinase activity of a CDK using pRb as a substrate. Progression of a cell through the cell cycle can be regulated by modulating ACDK expression in the cell.
    Type: Application
    Filed: July 19, 2002
    Publication date: May 11, 2006
    Inventors: Jin-Xiong She, Cong-Yi Wang, Pradeep Kumar
  • Activators of cyclin-dependent kinases
    Patent number: 7033816
    Abstract: A new gene family involved in cell cycle regulation was discovered. This family has been termed activators of cyclin-dependent kinases (ACDKs). A number of ACDK genes have been cloned and sequenced. Proteins encoded by ACDK genes specifically were shown to interact with CDKs and pRb, and to upregulate the kinase activity of a CDK using pRb as a substrate. Progression of a cell through the cell cycle can be regulated by modulating ACDK expression in the cell.
    Type: Grant
    Filed: July 19, 2002
    Date of Patent: April 25, 2006
    Assignee: University of Florida Research Foundation, Inc.
    Inventors: Jin-Xiong She, Cong-Yi Wang, Pradeep G. Kumar
  • Novel gene associated with type 1 diabetes and methods of use
    Publication number: 20050227272
    Abstract: Novel nucleic acids associated with Type 1 diabetes. Also provided are polypeptides encoded by the nucleic acids associated with T1D. The invention also provides methods for facilitating the diagnosis or pre-diagnosis of T1D through the use of such nucleic acids and polypeptides. This invention further provides compositions for the treatment of Type 1 diabetes.
    Type: Application
    Filed: March 25, 2005
    Publication date: October 13, 2005
    Inventors: Jin-Xiong She, Cong-Yi Wang